Molecular Imaging

U.S. DOE, MURR establish domestic Gd-153 supply

By AuntMinnie.com staff writers

The organizations are now positioned as the sole domestic supplier of the radioisotope and one of only two suppliers globally.

March 25, 2026

Clarity inks supply deal with Theragenics for Cu-64

By AuntMinnie.com staff writers

The deal adds to existing copper-64 supply agreements Clarity has with SpectronRx and Nusano.

March 25, 2026

New FAPI tracer shows promise across 19 solid tumor types

By Will Morton

PET using fibroblast activation protein inhibitor (FAPI) tracers has emerged as a robust imaging tool for detecting solid tumors.

March 23, 2026

FDG-PET matches MRI in cardiac imaging

By Will Morton

The finding is from a study of multiple PET acquisition techniques and cardiac MRI for measuring left ventricular ejection fraction.

March 20, 2026

BIDMC picks new molecular imaging, theranostics division chief

By AuntMinnie.com staff writers

Heather Jacene, MD, PhD, will become chief of molecular imaging and theranostics at Beth Israel Deaconess Medical Center (BIDMC).

March 20, 2026

Varian nets FDA clearance for TrueBeam in osteoarthritis treatment

By AuntMinnie.com staff writers

Varian has received U.S. FDA clearance for the use of low-dose radiation therapy with its Varian TrueBeam radiotherapy systems.

March 19, 2026

TerraPower Isotopes to build Ac-225 facility in Philadelphia

By AuntMinnie.com staff writers

The new site will increase the company's actinium-225 (Ac-225) production capacity 20-fold.

March 18, 2026

Clarity highlights Cu-64 PSMA-PET/CT study results

By AuntMinnie.com staff writers

The study compares Clarity's copper-64 (Cu-64) SAR-bisPSMA PET/CT agent with standard gallium-68 PSMA-11 PET/CT.

March 18, 2026

U.S. FDA extends review of Lantheus’ PET imaging kit for NETs

By AuntMinnie.com staff writers

LNTH-2501 is a PET diagnostic imaging kit for somatostatin receptor-positive neuroendocrine tumors (NETs).

March 18, 2026

Telix resubmits NDA for Pixclara brain cancer PET imaging agent

By AuntMinnie.com staff writers

The New Drug Application (NDA) resubmission includes additional data and statistical analysis requested by the U.S. FDA.

March 17, 2026

Study supports use of SPECT in Pluvicto patients

By Will Morton

The findings support the role of cycle 1 PSMA-SPECT for early on-treatment risk stratification.

March 16, 2026

ACR invites comment on head and neck imaging report elements

By AuntMinnie.com staff writers

The measure is intended to reduce report variation and promote timely, targeted follow‐up.

March 13, 2026

Page 1 of 622

Next Page